drugset / Trial / NCT02620345
Fibroids in Women of Reproductive Age and Women Pregnancy
RandomizedParallel-groupOpen-labelTreatment
Summary
Dydrogesterone Multivitamin Nature treatment of fibroids in women of reproductive age and women pregnancy to lost the size fibroids.
Timeline
- Start
- 2010-01
- Primary completion
- 2015-10
- Completion
- 2015-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dydrogesterone | Other / unclassified | 15 mg | — |
| Background | Calcium carbonate | Other / unclassified | 150 mg | — |
| Background | Cholecalciferol | Other / unclassified | 400 iu | — |
| Background | Dl-Alpha Tocopheryl Acetate | Unknown | 11 iu | — |
| Background | Ferrous Sulfate | Diagnostic / imaging agent | 27 mg | — |
| Background | Niacinamide | Unknown | 18 mg | — |
| Background | Pyridoxine | Unknown | 2.6 mg | — |
| Background | Riboflavin | Other / unclassified | 1.7 mg | — |
| Background | Vitamin B12 | Other / unclassified | 4 ug | — |
| Background | Vitamin C | Other / unclassified | 100 mg | — |
| Background | Zinc Oxide | Unknown | 25 mg | — |
| Background | beta-carotene | Small molecule | 4000 iu | — |
| Background | folic acid | Other / unclassified | 400 ug | — |
| Background | thiamine mononitrate | Unknown | 1.5 mg | — |